COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,730 Articles (22,502 medRxiv, 8,228 bioRxiv)

Most recent first Previous |  Page 1943: Articles 19421-19430  | Next

Smoking, distress and COVID-19 in England: cross-sectional population surveys from 2016 to 2020
Kock, L., Shahab, L., Brown, J., Moore, G., Horton, M., Brose, L.
10.1101/2020.12.07.20245514 — Posted: 2020-12-09
Theoretical Epidemic Laws Based on Data of COVID-19 Pandemic
Guo, J.
10.1101/2020.12.07.20238253 — Posted: 2020-12-09
Binding of SARS-CoV-2 spike protein to ACE2 is disabled by thiol-based drugs; evidence from in vitro SARS-CoV-2 infection studies.
Khanna, K., Raymond, W., Charbit, A. R., Jin, J., Gitlin, I., Tang, M., Sperber, H. S., Franz, S., Pillai, S., Simmons, G., Fahy, J. V.
10.1101/2020.12.08.415505 — Posted: 2020-12-08
Circular RNA profiling reveals abundant and diverse circRNAs of SARS-CoV-2, SARS-CoV and MERS-CoV origin
Yang, S., Zhou, H., Cruz-Cosme, R., Liu, M., Niu, X., Xu, J., Li, Y., Xiao, L., Wang, Q., Zhu, H., Tang, Q.
10.1101/2020.12.07.415422 — Posted: 2020-12-08
Engineered receptor binding domain immunogens elicit pan-coronavirus neutralizing antibodies
Hauser, B. M., Sangesland, M., Lam, E. C., Feldman, J., Yousif, A. S., Caradonna, T. M., Balazs, A. B., Lingwood, D., Schmidt, A. G.
10.1101/2020.12.07.415216 — Posted: 2020-12-08
Distant Residues Modulate the Conformational Opening in SARS-CoV-2 Spike Protein
Ray, D., Le, L., Andricioaei, I.
10.1101/2020.12.07.415596 — Posted: 2020-12-08
Extended in vitro inactivation of SARS-CoV-2 by titanium dioxide surface coating
Mlcochova, P., Chadha, A., Hesselhoj, T., Fraternali, F., Ramsden, J., Gupta, R. K.
10.1101/2020.12.08.415018 — Posted: 2020-12-08
Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component Andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives
Sa-ngiamsuntorn, K., Suksatu, A., Pewkliang, Y., Thongsri, P., Kanjanasirirat, P., Manopwisedjaroen, S., Charoensutthivarakul, S., Wongtrakoongate, P., Pitiporn, S., Khemawoot, P., Chutipongtanate, S., Borwornpinyo, S., Thitithanyanont, A., Hongeng, S.
10.1101/2020.12.08.415836 — Posted: 2020-12-08
Natural SARS-CoV-2 infections, including virus isolation, among serially tested cats and dogs in households with confirmed human COVID-19 cases in Texas, USA
Hamer, S. A., Pauvolid-Correa, A., Zecca, I. B., Davila, E., Auckland, L. D., Roundy, C. M., Tang, W., Torchetti, M. K., Killian, M. L., Jenkins-Moore, M., Mozingo, K., Akpalu, Y., Ghai, R. R., Spengler, J. R., Barton Behravesh, C., Fischer, R., Hamer, G. L.
10.1101/2020.12.08.416339 — Posted: 2020-12-08
Effect of COVID-19 response policies on walking behavior in US cities
Hunter, R. F., Garcia, L., de Sa, T. H., Zapata-Diomedi, B., Millett, C. J., Woodcock, J., Pentland, A., Moro, E.
10.1101/2020.12.07.20245282 — Posted: 2020-12-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).